Status:

RECRUITING

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

Lead Sponsor:

IRCCS San Raffaele

Conditions:

Prostate Cancer

Eligibility:

MALE

18-95 years

Brief Summary

This is a retrospective monoinstitutional study which analyses the results of advanced radiotherapy (IGRT, IMRT, SBRT, and PET-guided) performed for radical, adjuvant, or salvage purposes in patients ...

Detailed Description

This is a single-center, retrospective study (PROST-ART) that has as its primary objective the evaluation of the efficacy of radiotherapy treatments performed in patients with early-stage, advanced, m...

Eligibility Criteria

Inclusion

  • Prostate cancer patients, \> 18 years old, treated with IGRT, IMRT, SBRT

Exclusion

  • other tumors
  • \> 95 years old

Key Trial Info

Start Date :

February 14 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 14 2027

Estimated Enrollment :

2500 Patients enrolled

Trial Details

Trial ID

NCT06546267

Start Date

February 14 2022

End Date

December 14 2027

Last Update

June 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IRCCS San Raffaele Scientific Institute

Milan, Italy, 20132

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART) | DecenTrialz